Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Effects of inpatient traditional, complementary and integrative medicine (TCIM) care in Germany.

Official title: Effects of the Clinical Application of TCIM Procedures During Inpatient Stays in Germany - a Multicenter Observational Study

Run by Charite University, Berlin, Germany · NCT07040475 · Data updated 2026-11-12

This project will see if a routine package of inpatient TCIM therapies—like hyperthermia, exercise, mind‑body medicine, herbal and nutritional therapies including fasting—helps adults with chronic diseases admitted to participating German hospitals.

More Chronic Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2500 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Locations3 sites (Bamberg and 2 other locations)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedDecember 26, 2025
Trial IDNCT07040475 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic diseases who begin inpatient TCIM treatment within 24 hours at one of the participating hospitals and can give written informed consent.

Probably not a fit

Patients who are pregnant or breastfeeding, have severe cognitive impairment or insufficient language skills, are enrolled in another clinical study, or are not receiving inpatient TCIM likely will not benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project follows patients who begin routine inpatient TCIM care at three German hospitals to collect data on outcomes and safety. Patients receive a combination of evidence-based TCIM approaches such as hyperthermia, exercise therapy, mind‑body medicine, phytotherapy, nutritional therapy and fasting as part of usual care. Data are collected from the start of treatment and during the hospital stay to describe symptoms, functional status, adverse events and healthcare use. The design is non-randomized and evaluates the real-world effects of standard TCIM packages under current reimbursement arrangements.

Why it matters

Potential benefit: If successful, the findings could support wider use and reimbursement of integrated inpatient TCIM approaches and show improvements in patient symptoms, function, or safety.

How similar studies have gone: Components of TCIM such as exercise, mind‑body therapies, phytotherapy and nutritional approaches have some supporting evidence, but systematic evaluations of combined inpatient TCIM packages are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Beginning (first 24 hours) inpatient TCIM treatment at Immanuel Hospital Berlin, Bamberg Hospital, or Evangelische Kliniken Essen-Mitte
* Written consent form

Exclusion criteria:

* Insufficient language skills
* Dementia or other severely impairing cognitive disorders
* Pregnancy or breastfeeding
* Participation in a clinical study

Where it's running

  • Sozialstiftung Bamberg, Klinikum Bamberg
    Bamberg, Germany
    Recruiting
  • Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin
    Berlin, Germany
    Recruiting
  • Klinik für Naturheilkunde und Integrative Medizin, KEM
    Essen, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.